Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
11 pending office actions • 9 art units • 10 examiners • 0 of 11 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Axogen Corporation is currently managing 11 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 10 distinct examiners, which indicates a highly decentralized review process with a wide variety of individual perspectives. This distribution is further reflected at the organizational level, as the actions are spread across 9 distinct art units. This suggests that the company's biotechnology innovations are being evaluated by many different specialized groups within the patent office, requiring a versatile and broad-based prosecution strategy. Prosecution in this area often faces rigorous scrutiny regarding enablement and written description.
The busiest examiner, TYSON, MELANIE RUANO, is currently responsible for 2 pending office actions. While this is the highest concentration for any single individual, it still represents a small portion of the 11 pending office actions total. For the legal team, the challenge lies in maintaining consistency across 9 distinct art units while addressing the unique preferences of 10 distinct examiners. The fact that the busiest examiner handles only 2 pending office actions highlights the decentralized nature of the portfolio and the need for a coordinated approach to managing these active matters. This distribution ensures that the 11 pending office actions receive independent scrutiny.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (9%) |
| §102 only | 1 (9%) |
| Double-patenting + other | 2 (18%) |
| Multi-statute (no §101) | 7 (64%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TYSON, MELANIE RUANO | 2 | 68.2% | +19.1% |
| LABRANCHE, BROOKE N | 1 | 72.1% | +17.0% |
| SCHUBERG, LAURA J | 1 | 23.6% | +37.0% |
| MARSH, OWEN LEWIS | 1 | 66.7% | +50.0% |
| FOX, ALLISON M | 1 | 71.0% | +35.7% |
| WAX, ROBERT A | 1 | 25.7% | +3.9% |
| DORNA, CARRIE R | 1 | 72.3% | +27.9% |
| WESTON, ALYSSA G | 1 | 59.5% | +49.0% |
| MARCSISIN, ELLEN JEAN | 1 | 34.6% | +49.4% |
| TICHY, JENNIFER M.H. | 1 | 64.6% | +34.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18145873 | SYSTEMS AND METHODS FOR DETECTION OF LAMININ BETA-1 SUBUNIT WITHIN TISSUE | MARCSISIN, ELLEN JEAN | 30d |
| 18650265 | FASCICULATED NERVE GRAFTS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME | SCHUBERG, LAURA J | — |
| 18413173 | ELECTRICAL STIMULATION DEVICES AND RELATED CONTROLLERS AND METHODS | MARSH, OWEN LEWIS | — |
| 18401111 | NERVE GRAFTS AND METHODS OF PREPARATION THEREOF | FOX, ALLISON M | — |
| 18542454 | DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME | WAX, ROBERT A | — |
| 18531802 | ENGINEERED NERVE GRAFTS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME | TYSON, MELANIE RUANO | — |
| 18347279 | MULTI-LAYER AMNION PRODUCT, RELATED DEVICES, AND RELATED METHODS | WESTON, ALYSSA G | — |
| 18051353 | TISSUE WRAP DEVICE WITH ATTACHMENT FEATURES | TYSON, MELANIE RUANO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18145873 | SYSTEMS AND METHODS FOR DETECTION OF LAMININ BETA-1 SUBUNIT WITHIN TISSUE | MARCSISIN, ELLEN JEAN | 30d |
| 19047021 | BARBED DEVICES FOR SECURING TISSUE | LABRANCHE, BROOKE N | — |
| 18650265 | FASCICULATED NERVE GRAFTS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME | SCHUBERG, LAURA J | — |
| 18413173 | ELECTRICAL STIMULATION DEVICES AND RELATED CONTROLLERS AND METHODS | MARSH, OWEN LEWIS | — |
| 18401111 | NERVE GRAFTS AND METHODS OF PREPARATION THEREOF | FOX, ALLISON M | — |
| 18531802 | ENGINEERED NERVE GRAFTS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME | TYSON, MELANIE RUANO | — |
| 18496100 | CAPTURE TOOL | DORNA, CARRIE R | — |
| 18347279 | MULTI-LAYER AMNION PRODUCT, RELATED DEVICES, AND RELATED METHODS | WESTON, ALYSSA G | — |
| Art Unit | Apps |
|---|---|
| 1633 | 2 |
| 3774 | 2 |
| 3771 | 1 |
| 1631 | 1 |
| 3796 | 1 |
| 1615 | 1 |
| 3791 | 1 |
| 1677 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19047021 | BARBED DEVICES FOR SECURING TISSUE | LABRANCHE, BROOKE N | 3771 | §102 | Non-Final OA | — | Pending | Feb 06, 2025 |
| 18650265 | FASCICULATED NERVE GRAFTS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME | SCHUBERG, LAURA J | 1631 | §102§103§112DP | Non-Final OA | — | Pending | Apr 30, 2024 |
| 18413173 | ELECTRICAL STIMULATION DEVICES AND RELATED CONTROLLERS AND METHODS | MARSH, OWEN LEWIS | 3796 | §103§112 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18401111 | NERVE GRAFTS AND METHODS OF PREPARATION THEREOF | FOX, ALLISON M | 1633 | §102§103§112 | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18542454 | DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME | WAX, ROBERT A | 1615 | §103 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18531802 | ENGINEERED NERVE GRAFTS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME | TYSON, MELANIE RUANO | 3774 | §102§103 | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18496100 | CAPTURE TOOL | DORNA, CARRIE R | 3791 | §102§103DP | Non-Final OA | — | Pending | Oct 27, 2023 |
| 18347279 | MULTI-LAYER AMNION PRODUCT, RELATED DEVICES, AND RELATED METHODS | WESTON, ALYSSA G | 1633 | §102§103 | Final Rejection | — | Pending | Jul 05, 2023 |
| 18145873 | SYSTEMS AND METHODS FOR DETECTION OF LAMININ BETA-1 SUBUNIT WITHIN TISSUE | MARCSISIN, ELLEN JEAN | 1677 | §103§112 | Non-Final OA | 30d | Pending | Dec 23, 2022 |
| 18051353 | TISSUE WRAP DEVICE WITH ATTACHMENT FEATURES | TYSON, MELANIE RUANO | 3774 | §103§112 | Non-Final OA | — | Pending | Oct 31, 2022 |
| 18049327 | NERVE CULTURE SYSTEM | TICHY, JENNIFER M.H. | 1653 | §102§103 | Final Rejection | — | Pending | Oct 25, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAxogen Corporation has 11 pending office actions as of October 2026, spread across 9 art units and 10 examiners.
Melanie Ruano Tyson has the most, with 2 of Axogen Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
